Galena Biopharma (GALE) to Present Data from NeuVax Phase 2
Tweet Send to a Friend
Galena Biopharma (Nasdaq: GALE) announced an oral presentation given today at the American College of Surgeons Clinical Congress 2013 taking ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE